vTv Therapeutics Inc. (VTVT)
USD 14.92
(-3.56%)
USD 14.92
(-3.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.01 Million | 4 Million | 6.41 Million | 2.76 Million | 12.43 Million |
| Cost of Revenue | 13.59 Million | 92 Thousand | 89 Thousand | 11.01 Million | 15.11 Million | 23.03 Million |
| Gross Profit | -13.59 Million | 1.92 Million | 3.91 Million | -4.6 Million | -12.35 Million | -10.6 Million |
| Operating Expenses | 11.9 Million | 24.55 Million | 25.66 Million | 18.26 Million | 23.65 Million | 32.25 Million |
| Selling, General and Administrative Expenses | 11.9 Million | 12.2 Million | 12.34 Million | 7.25 Million | 8.53 Million | 9.22 Million |
| Research and Development Expenses | 13.59 Million | 12.35 Million | 13.32 Million | 11.01 Million | 15.11 Million | 23.03 Million |
| Other Expenses | -13.59 Million | -2.67 Million | 4.05 Million | -270 Thousand | 828 Thousand | -592 Thousand |
| Cost and Expenses | 25.5 Million | 24.55 Million | 25.66 Million | 18.26 Million | 23.65 Million | 32.25 Million |
| Operating Income | -25.5 Million | -22.54 Million | -21.66 Million | -11.85 Million | -20.89 Million | -19.82 Million |
| Interest Expense | 13 Thousand | 15 Thousand | 12 Thousand | 692 Thousand | 1.82 Million | 3.29 Million |
| Income Tax Expense | - | 200 Thousand | 115 Thousand | -3.97 Million | 100 Thousand | 200 Thousand |
| Earnings before Tax | -25.96 Million | -24.87 Million | -17.61 Million | -12.8 Million | -21.83 Million | -23.64 Million |
| Net Income | -20.25 Million | -25.07 Million | -17.73 Million | -8.82 Million | -21.93 Million | -7.91 Million |
| Earnings Per Share Basic | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 |
| Earnings Per Share Diluted | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 |
| Weighted Average Shares Outstanding | 2.08 Million | 1.91 Million | 1.56 Million | 1.17 Million | 757.3 Thousand | 311.23 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.08 Million | 1.91 Million | 1.56 Million | 1.17 Million | 757.3 Thousand | 311.23 Thousand |
| Gross Margin | - | 0.95 | 0.98 | -0.72 | -4.47 | -0.85 |
| EBIT Margin | - | -12.32 | -4.40 | -1.89 | -7.24 | -1.64 |
| Profit Margin | - | -12.42 | -4.43 | -1.38 | -7.94 | -0.64 |
| EBITDA | -25.41 Million | -24.76 Million | -17.51 Million | -12.01 Million | -19.97 Million | -20.13 Million |
| Earnings Before Tax Margin | - | -11.17 | -5.41 | -1.85 | -7.56 | -1.59 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 1 Million | -9000.00 | - | - | 9000.00 |
| Cost of Revenue | 23 Thousand | 22 Thousand | 23 Thousand | 90 Thousand | 22 Thousand | 23 Thousand |
| Gross Profit | -23 Thousand | 978 Thousand | -32 Thousand | -90 Thousand | -22 Thousand | -14 Thousand |
| Operating Expenses | 7.13 Million | 6.6 Million | 4.68 Million | 25.41 Million | 5.36 Million | 8 Million |
| Selling, General and Administrative Expenses | 3.71 Million | 3.97 Million | 2.56 Million | - | 2.54 Million | 3.3 Million |
| Research and Development Expenses | 3.41 Million | 2.62 Million | 2.11 Million | - | 2.82 Million | 4.69 Million |
| Other Expenses | 193 Thousand | -371 Thousand | 185 Thousand | - | -3.29 Million | 638 Thousand |
| Cost and Expenses | 7.15 Million | 6.62 Million | 4.7 Million | 25.5 Million | 5.36 Million | 8 Million |
| Operating Income | -7.15 Million | -5.62 Million | -4.7 Million | -25.5 Million | -6.65 Million | -8 Million |
| Interest Expense | - | - | 7000.00 | 13 Thousand | -4000.00 | 2000.00 |
| Income Tax Expense | -1.22 Million | 100 Thousand | -963 Thousand | -5.71 Million | -3.32 Million | -952 Thousand |
| Earnings before Tax | -6.4 Million | -5.91 Million | -4.44 Million | -25.96 Million | -6.65 Million | -7.21 Million |
| Net Income | -5.18 Million | -4.86 Million | -3.47 Million | -20.25 Million | -6.65 Million | -5.61 Million |
| Earnings Per Share Basic | -0.81 | -1.17 | -1.67 | - | -3.27 | -2.76 |
| Earnings Per Share Diluted | -0.81 | -1.17 | -1.67 | - | -3.27 | -2.76 |
| Weighted Average Shares Outstanding | 6.4 Million | 4.14 Million | 2.08 Million | 2.08 Million | 2.03 Million | 2.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.4 Million | 4.14 Million | 2.08 Million | 2.08 Million | 2.03 Million | 2.03 Million |
| Gross Margin | - | 0.98 | 3.56 | - | - | -1.56 |
| EBIT Margin | - | -5.60 | 520.44 | - | - | -798.44 |
| Profit Margin | - | -4.86 | 386.44 | - | - | -624.33 |
| EBITDA | -7.13 Million | -5.6 Million | -4.68 Million | - | -6.65 Million | -7.18 Million |
| Earnings Before Tax Margin | - | -5.63 | 523.00 | - | - | -888.89 |
SUS
MRMD
MTO
1798
4731
ROSB